about
The release of fibroblast growth factor-1 from melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-kinase/Akt intracellular signaling pathwayPulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort studyThree-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metforminIn-hospital management and outcome in women with acute myocardial infarction (data from the AMI-Florence Registry).Early discharge after acute myocardial infarction in the current clinical practice. Community data from the AMI-Florence Registry, Italy.Usefulness and safety of shortened head-up tilt testing potentiated with sublingual glyceryl trinitrate in older patients with recurrent unexplained syncope.Diagnosis and characteristics of syncope in older patients referred to geriatric departments.Role of early symptoms in assessment of syncope in elderly people: results from the Italian group for the study of syncope in the elderly.[Evaluation of "complex syncope: what are the indications for second-level investigations?].Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study.Two-year morbidity and mortality in elderly patients with syncope.Fall prevention in the elderly.Neuroautonomic evaluation of patients with unexplained syncope: incidence of complex neurally mediated diagnoses in the elderly.Assessment of a structured management pathway for patients referred to the Emergency Department for syncope: results in a tertiary hospital.Safety and tolerability of Tilt Testing and Carotid Sinus Massage in the octogenarians.Etiology of Syncope and Unexplained Falls in Elderly Adults with Dementia: Syncope and Dementia (SYD) Study.Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)Effect of comorbidity on coronary reperfusion strategy and long-term mortality after acute myocardial infarction.
P50
Q24318686-0605E683-722E-45D2-ADF8-37DD962C60D4Q28193169-34C67164-C6DE-413A-A1B8-EB45E25D8050Q28236207-17500C2B-34D8-4402-8FC3-BDE6C95547C4Q30974602-8FF432D5-F333-4D65-B5D7-E8A0F160288FQ31041462-D3B53B36-CEA3-4E93-8DC1-5A0A1DB8E0E0Q33147973-2E6FEF31-6921-4967-86BA-6FE50982326FQ33154359-29227121-1D5D-4B93-98EF-61BA6881DC01Q33156878-39A63C9A-8D7A-47A9-8950-F5971DDBBFF9Q33157220-8372E239-37F7-498E-A427-2DFA2E0D7A59Q33158397-892BC08E-EED9-4A5E-8A34-F1463CB5679FQ33160440-5D065F10-81F9-4E87-AA67-18CCAFD05E48Q33163414-A2E4859E-70D1-4B94-8F32-480FD15F10B3Q33163922-0BED4B6B-18D2-4AD5-AE58-5BBB4AF3EADFQ33165736-AFD7BC06-94A3-4066-938D-7CA08E214EF0Q33166763-5F1CB682-0BF9-420C-9FA6-633A0ABEF63DQ33167349-962833F9-959F-4E09-93A6-82755F5E3F6BQ33168318-530DB002-E7DF-4817-BD17-84D3C9B3012BQ33241433-28B15F28-41AA-41A9-839A-0201671994C0
P50
description
onderzoeker
@nl
name
Niccolò Marchionni
@ast
Niccolò Marchionni
@en
Niccolò Marchionni
@nl
Niccolò Marchionni
@sl
type
label
Niccolò Marchionni
@ast
Niccolò Marchionni
@en
Niccolò Marchionni
@nl
Niccolò Marchionni
@sl
prefLabel
Niccolò Marchionni
@ast
Niccolò Marchionni
@en
Niccolò Marchionni
@nl
Niccolò Marchionni
@sl